- Adv. Search & Platform Tools
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Glass Ceiling Report
- Global 20
- Law360 400
- Diversity Snapshot
- Practice Group Partner Rankings
- Practice Groups of the Year
- Pro Bono Firms of the Year
- Rising Stars
- Trial Aces
- Site Menu
- Join the Law360 team
- Search legal jobs
- Learn more about Law360
- Read testimonials
- Contact Law360
- Sign up for our newsletters
- Site Map
- Help
We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close
December 8, 2017
In Re: National Prescription Opiate Litigation
Case Number:
1:17-md-02804
Court:
Nature of Suit:
Multi Party Litigation:
Multi-district Litigation
Judge:
Companies
- Actavis PLC
- Allergan PLC
- AmerisourceBergen Corporation
- Cardinal Health Inc.
- Cephalon, Inc.
- Endo International Plc
- Johnson & Johnson
- McKesson Corp.
- Purdue Pharma LP
- Teva Pharmaceutical Industries Limited
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
May 10, 2018
Opioid MDL Judge Says Litigation Track Is A Settlement Aid
The Ohio federal judge overseeing the massive multidistrict litigation over the opioid epidemic said Thursday that the newly formed litigation track is no substitute for a settlement, emphasizing his goal of reaching a quick resolution to the litigation.
Parties
To view the parties, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login